Why do some non-smokers get COPD while many heavy smokers don’t?
A new study highlights a strong risk factor for COPD related to lung development
RI-MUHC trainee wins scholarship from the Société québécoise d’hypertension artérielle
Congratulations to Joseph Mussa!
Hydroxychloroquine not effective in preventing the development of COVID-19 when used as post-exposure prophylaxis
A new study suggests that hydroxychloroquine is not effective in preventing the development of COVID-19 in individuals exposed to SARS-CoV-2
Results of MI4 Emergency COVID-19 Research Funding (Round 2)
RI-MUHC researchers awarded MUHC Foundation funding for a second round of projects with potential impact in a short timeframe
National study to collect data on aging adults’ experiences during COVID-19 pandemic
Christina Wolfson is co-principal investigator on a new national study
Best poster presentation at meeting of the CIHR Drug Safety Effectiveness Network
Congratulations to Marina Machado!
RI-MUHC researchers review diagnostic tests for COVID-19
Study published in the Annals of Internal Medicine
Results of MI4 Emergency COVID-19 Research Funding (Round 1)
RI-MUHC researchers awarded MUHC Foundation funding for projects with potential impact in a short timeframe
RI-MUHC innovative clinical trial assesses hydroxychloroquine for prevention and treatment of COVID-19
Initially restricted to health care workers in Quebec, the clinical study is now open to all eligible adults
COVID-19 coronavirus and tuberculosis: We need a damage control plan
Dr. Madhukar Pai explains why TB services might be one of the biggest casualties of the pandemic